Researchers Announce Results of New COVID-19 sa-mRNA Vaccine
The findings suggest that 6 months after vaccination with ARCT-154, individuals had a longer immune response.
Source: pharmacytimes.com
Jonathan Edelman News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Jonathan Edelman. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Jonathan Edelman Today - Breaking & Trending Today
Weekly Rounds: Round Table on Burnout, Climate Change and Infectious Diseases, and More
Take 5 minutes to catch up on Infection Control Today®’s highlights for the week ending February 4, 2024.
Source: infectioncontroltoday.com
CSL's ARCT-154: The World's First Self-Amplifying mRNA Vaccine Approved for COVID-19 in Adults
CSL achieves a global milestone as Japan approves ARCT-154, the first sa-mRNA COVID-19 vaccine, showcasing CSL's commitment to innovation, efficacy, and prolonged protection against variants. Jonathan Edelman, MD, senior VP of CSL Vaccine’s Innovation Unit, speaks with ICT.
Source: infectioncontroltoday.com
CSL and Arcturus Therapeutics' ARCT-154 Demonstrates Non-Inferiority to Original Strain and Superior Immunogenicity to Omicron BA.4/5 Variant Compared to First-Generation mRNA Vaccine Booster Seite 1
21.12.2023 - Global biotechnology leader CSL (ASX:CSL; USOTC:CSLLY) and Arcturus Therapeutics (Nasdaq: ARCT) today announced the publication in Lancet Infectious Diseases of a Phase 3 study showing that a booster dose of ARCT-154, a novel, self-amplifying ... Seite 1
Source: wallstreet-online.de
Japan's Ministry of Health, Labour and Welfare Approves CSL and Arcturus Therapeutics' ARCT-154, the First Self-Amplifying mRNA Vaccine Approved for COVID in Adults | Region
KING OF PRUSSIA, Pa. & SAN DIEGO--(BUSINESS WIRE)--Nov 28, 2023--
Source: eagletribune.com